Evidence map›Paper›PMID 32194570›Full record

ReviewFrontiers in immunology2020

Role of Viral and Host microRNAs in Immune Regulation of Epstein-Barr Virus-Associated Diseases.

Hisashi Iizasa, Hyoji Kim, Andy Visi Kartika, Yuichi Kanehiro, Hironori Yoshiyama

Erratum issuedOpen access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Viral oncogenesis in cancer: from mechanisms to therapeutics.Signal transduction and targeted therapy · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hisashi IizasaDepartment of Microbiology, Faculty of Medicine, Shimane University, Shimane, Japan.
Hyoji KimDepartment of Microbiology, Faculty of Medicine, Shimane University, Shimane, Japan.
Andy Visi KartikaDepartment of Microbiology, Faculty of Medicine, Shimane University, Shimane, Japan.
Yuichi KanehiroDepartment of Microbiology, Faculty of Medicine, Shimane University, Shimane, Japan.
Hironori YoshiyamaDepartment of Microbiology, Faculty of Medicine, Shimane University, Shimane, Japan.
Shimane University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epstein-Barr virus (EBV) is an oncogenic human herpes virus that was discovered in 1964. Viral non-coding RNAs, such as

Indexed as

Gene Expression Regulation, ViralAdaptive ImmunityAlternative SplicingCarcinomaCytopathogenic Effect, ViralEpithelial CellsEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHost-Pathogen InteractionsHumansImmune EvasionImmunity, InnateImmunologic SurveillanceLymphomaMicroRNAsNasopharyngeal NeoplasmsBHRF1 protein, Human herpesvirus 4EBV-associated membrane antigen, Epstein-Barr virusEBV-BART10-3p microRNAMicroRNAsRNA, ViralViral Matrix ProteinsViral ProteinsBART miRNABHRF miRNAherpes virusimmune evasionmicroRNAs

Identifiers

PMID32194570
PMCPMC7062708
OpenAlexW3009978482

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.